XML 31 R18.htm IDEA: XBRL DOCUMENT v3.23.1
Note 4 - Income Taxes (Tables)
12 Months Ended
Dec. 31, 2022
Notes Tables  
Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]
  

Years Ended December 31,

 
  

2022

  

2021

 

U.S. operations

 $(9,828,427) $(13,115,869)

Foreign operations

  93,169   45,618 

Total loss before provision for income taxes

 $(9,735,258) $(13,070,251)
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]
  

Years Ended December 31,

 
  

2022

  

2021

 

Tax at U.S. statutory rate

  (21.00)%  (21.00)%

State taxes, net of federal benefit

  (4.35)  (4.52)

Non-deductible items

     (0.84)

Change in valuation allowance

  24.77   28.09 

True-up adjustment

  0.34   0.06 

Foreign operations

  0.24   0.09 

Change in tax rate

     (1.88)

Other

      

Effective income tax rate

  %  %
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]
  

December 31,

 
  

2022

  

2021

 

Stock option expense

 $1,341,900  $947,400 

NOL carryforward

  11,524,900   10,509,900 

Research and development credits

  1,623,100   1,656,500 

Section 174 - R&D expenses

  1,046,400    

Unrealized gain from investment in Alphazyme

     (72,100)

Other

  (78,200)  (6,100)

Deferred tax asset, net of deferred tax liabilities

  15,458,100   13,035,600 

Valuation allowance

  (15,458,100)  (13,035,600)

Net deferred tax asset

 $  $